Russia's war in Ukraine is now delaying data readouts, as Tricida says its second-chance trial needs more time
A small cap biotech reported Wednesday that the Russian invasion of Ukraine will delay the interim analysis for a large study, suggesting the war could …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
